Skip to main content
. 2022 Jan 13;14(1):185. doi: 10.3390/pharmaceutics14010185

Figure 7.

Figure 7

Effects of NLC Placebo, NLC Riluzole, functionalized NLC, and free riluzole exposure on the viability of NCS-34 (A) and hCMEC/D3 (B) cells at different concentrations (0.1–10 μM), as measured by the MTT assay. Values are expressed as mean ± SD (n = 6). Different letters (a,b) mean significant differences between concentrations of the same sample (p < 0.05) according to Tukey’s HSD test.